5 results
IDSA Recommendations for Treating Cytomegalovirus Infections in HIV-AIDS
Preventing CMV Disease:
 • CMV end-organ disease is best
IDSA Recommendations ... retinitis should ... intraocular levels of drug ... #IDSA #Prevention ... #HIVAIDS #pharmacology
IDSA - Clinical Strategy to Build an Individualized Treatment Regimen for Multi-Drug Resistant Tuberculosis (MDR-TB)
 •
IDSA - Clinical ... are contacts of infectious ... isolate DST result should ... antimicrobials #regimens #pharmacology ... #dosing #idsa #
IDSA Recommendations for Preventing and Treating Disseminated Mycobacterium Avium Complex in HIV-AIDS
Preventing 1st Episode of Disseminated
IDSA Recommendations ... Note: Active TB should ... Mycobacterium #AviumComplex ... opportunistic #infections ... #HIVAIDS #pharmacology
Rybelsus (oral semaglutide) - First Oral GLP-1 Agonist
Dosing:
3 mg daily x 30 days, then 7 mg
order for the drug ... Patients should ... to ensure the drug ... patients to take meds ... semaglutide #Diabetes #Pharmacology
IDSA Recommendations for Treating Mycobacterium Tuberculosis Infection and Disease in HIV-AIDS
Treating LTBI (to prevent TB disease)
Indications:
IDSA Recommendations ... a person with infectious ... empiric treatment should ... Tuberculosis #TB #IDSA ... #HIVAIDS #pharmacology